Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MICROGLIAL DYSFUNCTION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | MICROGLIAL DYSFUNCTION |
graph TD
MICROGLIAL_DYSFUNCTION[MICROGLIAL DYSFUNCTION]
MICROGLIAL_DYSFUNCTION -->|drives| neurodegeneration[neurodegeneration]
MICROGLIAL_DYSFUNCTION -->|causes| Neurodegeneration[Neurodegeneration]
MICROGLIAL_DYSFUNCTION -->|causes| Amyotrophic_Lateral_Sclerosis[Amyotrophic Lateral Sclerosis]
MICROGLIAL_DYSFUNCTION -->|contributes to| Perineuronal_Nets_Accumulation[Perineuronal Nets Accumulation]
STING[STING] -->|causes| MICROGLIAL_DYSFUNCTION
Apoe4[Apoe4] -->|causes| MICROGLIAL_DYSFUNCTION
Lipid_Droplets[Lipid Droplets] -->|mediates| MICROGLIAL_DYSFUNCTION
Lipid_Droplet_Accumulation[Lipid Droplet Accumulation] -->|causes| MICROGLIAL_DYSFUNCTION
Nfkb[Nfkb] -->|mediates| MICROGLIAL_DYSFUNCTION
STING_INHIBITION[STING INHIBITION] -->|alleviates| MICROGLIAL_DYSFUNCTION
STREM2[STREM2] -->|triggers| MICROGLIAL_DYSFUNCTION| Target | Relation | Type | Str |
|---|---|---|---|
| Impaired α-synuclein clearance | causes | Molecular mechanism | 1.00 |
| neurodegeneration | drives | disease | 0.95 |
| Neurodegeneration | causes | disease | 0.88 |
| Amyotrophic Lateral Sclerosis | causes | disease | 0.85 |
| Perineuronal Nets Accumulation | contributes_to | phenotype | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SCFA deficiency | drives | Metabolic state | 1.00 |
| STING | causes | protein | 0.95 |
| STING | activates | protein | 0.95 |
| STING | promotes | protein | 0.95 |
| Apoe4 | causes | biomarker | 0.90 |
| Lipid Droplets | mediates | process | 0.90 |
| Lipid Droplet Accumulation | causes | phenotype | 0.90 |
| Nfkb | mediates | pathway | 0.82 |
| STING | causes | gene | 0.80 |
| STING INHIBITION | alleviates | drug | 0.80 |
| STREM2 | triggers | protein | 0.80 |
| TREM2 dysregulation | causes (disease-associated microglia show dysregulated TRE) | mechanism | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| PLCG2 Allosteric Modulation as a Precision Therapeutic for T | 0.941 | neurodegeneration | TREM2 agonism vs antagonism in DAM micro |
| TREM2-Mediated Microglial Dysfunction Disrupts Perivascular | 0.812 | neuroscience | TREM2 in Alzheimer's Disease: Mechanisms |
| TREM2-Mediated Microglial Dysfunction Disrupts Oligodendrocy | 0.691 | neuroscience | Circuit-level neural dynamics in neurode |
| TREM2 Agonism to Rescue APOE4-Induced Microglial Dysfunction | 0.690 | neurodegeneration | APOE4 targeting in neurodegeneration |
| TREM2-Astrocyte Communication in Microglial Dysfunction | 0.579 | neurodegeneration | Gene expression changes in aging mouse b |
| TREM2-Mediated Microglial Dysfunction Drives Tau-Induced Blo | 0.499 | neuroscience | Circuit-level neural dynamics in neurode |
| APOE and TREM2 interact to modulate age-dependent microglial | 0.467 | Alzheimer's disease | Allen Mouse Brain Aging Atlas: cross-age |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-26 | 4 hypotheses Top: 7.200
neurodegeneration | 2026-04-03 | 7 hypotheses Top: 0.726
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| E2F coordination of G2/M transcriptional program | exploratory | 0.750 | 0.00 | endocycling mammalian cells | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] | Zhou Y, Song WM, Andhey PS, Swain A, Lev | Nat Med | 2020 | 1 |
| Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Thera [PMID:40922457] | ["Eroglu E", "Harmanci N"] | Basic & clinical pharmacology | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] | Zhou Y, Song WM, Andhey PS, Swain A, Lev | Nat Med | 2020 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Multiple Sclerosis Pathology. [PMID:29358320] | Lassmann H | Cold Spring Harbor perspective | 2018 | 0 |
| Recent Advances from the Bench Toward the Bedside in Alzheimer's Disease [PMID:26137544] | Macauley SL, Holtzman DM | EBioMedicine | 2015 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.00 · 2026-04-26
closed · Rounds: 4 · Score: 0.00 · 2026-04-26
closed · Rounds: 4 · Score: 0.00 · 2026-04-26
closed · Rounds: 4 · Score: 0.00 · 2026-04-26
active · Rounds: 4 · Score: 1.00 · 2026-04-26
closed · Rounds: 4 · Score: 0.95 · 2026-04-03
Hypotheses and analyses mentioning MICROGLIAL DYSFUNCTION in their description or question text
Score: 0.499 · neuroscience · 2026-04-21
## Mechanistic Overview TREM2-Mediated Microglial Dysfunction Drives Tau-Induced Blood-Brain Barrier Breakdown starts fr
Score: 0.467 · Alzheimer's disease · 2026-04-23
## Mechanistic Overview APOE and TREM2 interact to modulate age-dependent microglial dysfunction starts from the claim t